Randomized Phase 3 Study of Panitumumab With FOLFOX4 Compared to FOLFOX4 Alone as 1(st)-line Treatment (tx) for Metastatic Colorectal Cancer (mCRC): The PRIME Trial

Por Douillard, J.Y., Siena, S., Cassidy, J., Tabernero, J., Burkes, R., Barugel, M.E., Humblet, Y., Cunningham, D., Wolf, M., Gansert, J.
Publicado em 2010